DiaGen AI
Díagen is an AI-driven company revolutionizing drug discovery and development by integrating generative AI into protein and peptide design. Their platform, "Día", aims to significantly shorten the lengthy, costly, and high-risk drug development process, which typically takes 10-15 years. Díagen's technology addresses global challenges across multiple facets of health, with applications in drug discovery, trial acceleration, diagnostics, biosensors, and stabilizing agents. They offer their "Día" engine through various business models including white-labeling, consultancy, research partnerships, and licensing of their designed peptides and proteins. The company has a strong focus on R&D with ongoing projects in in vitro diagnostics for heart attack and sinusitis, oncology drugs, universal flu vaccines, HIV vaccines, and nanobody optimization. Díagen also highlights successful experimental validation in oncology and diagnostics.
DiaGen AI
Díagen is an AI-driven company revolutionizing drug discovery and development by integrating generative AI into protein and peptide design. Their platform, "Día", aims to significantly shorten the lengthy, costly, and high-risk drug development process, which typically takes 10-15 years. Díagen's technology addresses global challenges across multiple facets of health, with applications in drug discovery, trial acceleration, diagnostics, biosensors, and stabilizing agents. They offer their "Día" engine through various business models including white-labeling, consultancy, research partnerships, and licensing of their designed peptides and proteins. The company has a strong focus on R&D with ongoing projects in in vitro diagnostics for heart attack and sinusitis, oncology drugs, universal flu vaccines, HIV vaccines, and nanobody optimization. Díagen also highlights successful experimental validation in oncology and diagnostics.